Source: PR Newswire

Press Release: Creganna Medical : Anaconda Biomed Engages Creganna Medical

BARCELONA, Spain, April 24, 2017 /PRNewswire/ -- Anaconda BioMed, a pre-clinical stage medical device company focused on the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna Medical to...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more